Notably, genomic defects in CRBN, including mutations, copy number loss, transcriptomic aberrations (epigenetic, RNA splicing/stability), and specific exon10-deleted splice transcript variant, increase in IMiD-resistant relapsed and refractory MM (RRMM) patients. Here, CRBN is linked to Miyoshi myopathy.